| Myeloproliferative neoplasms (MPN) |
|
| Polycythemia vera |
5 |
| Primary myelofibrosis |
8 |
| Essential thrombocythemia |
18 |
| Myelodysplastic syndrome (MDS) |
|
| Refractory anemia with excess blasts |
3 |
| Acute myeloid leukemia (AML) with recurrent genetic abnormalities |
|
| AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
|
9 |
| AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
|
3 |
| APL with t(15;17)(q22;q12); PML-RARA
|
9 |
| AML with t(9;11)(p22;q23); MLLT3-KMT2A
|
1 |
| AML with mutated NPM1
|
14 |
| AML with biallelic mutations of CEBPA
|
8 |
| AML with myelodysplasia-related changes |
14 |
| Therapy-related myeloid neoplasms |
1 |
| AML, NOS |
|
| AML without maturation |
3 |
| AML with maturation |
27 |
| Acute myelomonocytic leukemia |
3 |
| Acute monoblastic/monocytic leukemia |
2 |
| Myeloid proliferations related to Down syndrome |
1 |
| Total |
129 |
